# Roche Molecular Systems, Inc. – FDA Inspection, Dec 8, 2023

Source: https://www.keypedia.com/records/fda_inspections/roche-molecular-systems-inc/3562058a-f301-4312-9965-513037ddb191
Source feed: FDA_Inspections

> FDA inspection 1224711 of Roche Molecular Systems, Inc., December 08, 2023. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR parts 606 and 820. Form 483 issued. 14 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1224711
- Company Name: Roche Molecular Systems, Inc.
- Inspection Date: 2023-12-08
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 4

## Related Documents

- FDA Inspection 1323692 - 2026-06-12
- FDA Inspection 1100926 - 2019-07-31
- FDA Inspection 1027092 - 2017-07-24
- [FDA Inspection 1020421 - 2017-07-19](https://www.keypedia.com/records/fda_inspections/roche-molecular-systems-inc/61eafec8-5360-49e5-a7c3-050777797698)
- [FDA Inspection 979955 - 2016-07-13](https://www.keypedia.com/records/fda_inspections/roche-molecular-systems-inc/db713e62-1033-44e3-b201-a6d310a540c6)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/christian-lynch/ee342d8e-9fcf-4c84-9494-ceaf6320faf6)
- [Issuing Officer](https://www.keypedia.com/people/nisha-c-patel/1b38764f-c7bc-4f90-9af1-54989ad6d59c)
- [Company Rep](https://www.keypedia.com/people/richard-t-riggie/d07a4551-08b4-44f7-b7d2-02ae3c5dc1e2)

Company: https://www.keypedia.com/companies/roche-molecular-systems-inc/603d5520-1c54-4282-88f0-76549211cf07

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
